Loading clinical trials...
Loading clinical trials...
A Feasibility Study of Electronic Medication Adherence Reminders and Side Effect Management by an Artificial Intelligence ChatBot Via Mobiles Phones Among Patients With Gastrointestinal Cancers
Conditions
Interventions
'Penny' via Memora Platform
Locations
1
United States
Abramson Cancer Center
Philadelphia, Pennsylvania, United States
Start Date
August 2, 2021
Primary Completion Date
November 5, 2024
Completion Date
November 8, 2024
Last Updated
December 17, 2024
NCT04674267
NCT06596694
NCT06445062
NCT01313442
NCT06511037
NCT05789485
Lead Sponsor
Abramson Cancer Center at Penn Medicine
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions